Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patient.
<h4>Background</h4>Neurofibromatosis type I (NF1, MIM#162200) is a relatively frequent genetic condition, which predisposes to tumor formation. Apart from tumors, individuals with NF1 often exhibit endocrine abnormalities such as precocious puberty (2,5-5% of NF1 patients) and some cases...
Main Authors: | Karolina Kobus, Daniela Hartl, Claus Eric Ott, Monika Osswald, Angela Huebner, Maja von der Hagen, Denise Emmerich, Jirko Kühnisch, Hans Morreau, Frederik J Hes, Victor F Mautner, Anja Harder, Sigrid Tinschert, Stefan Mundlos, Mateusz Kolanczyk |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0119030 |
Similar Items
-
Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.
by: Jirko Kühnisch, et al.
Published: (2014-01-01) -
Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin
by: Osswald Monika, et al.
Published: (2008-07-01) -
MIA is a potential biomarker for tumour load in neurofibromatosis type 1
by: Holtkamp Nikola, et al.
Published: (2011-07-01) -
Role of Cytosolic 2-Cys Prx1 and Prx2 in Redox Signaling
by: Yosup Kim, et al.
Published: (2019-06-01) -
Atypical <i>NF1</i> Microdeletions: Challenges and Opportunities for Genotype/Phenotype Correlations in Patients with Large <i>NF1</i> Deletions
by: Hildegard Kehrer-Sawatzki, et al.
Published: (2021-10-01)